Naprod Life Science leads India's self-reliant surge in global cancer drug market

In a significant stride towards self-reliance, Naprod Life Science is at the forefront of India's burgeoning pharmaceutical sector, particularly in the production of high-quality cancer medicines. Operating in over 40 regulated markets worldwide, the company exemplifies India's capability to meet global demand with innovative and affordable healthcare solutions. Mohan Jain, Director of Naprod Life Science in an exclusive interview with Shardul Nautiyal discusses Naprod's competitive edge, the importance of an integrated supply chain, and future plans to expand their footprint in regulated markets while navigating the challenges of the global pharmaceutical landscape.